NEW YORK ( TheStreet) -- CHANGE IN RATINGSAmerican Eagle ( AEO) was upgraded at Brean Murray from Hold to Buy. $23 price target. Estimates were also boosted, given drastic changes from the new CEO, Brean Murray said. Alpha Natural ( ANR) was upgraded at Brean Murray from Hold to Buy. Valuation call, based on a $15 price target, Brean Murray said. Avon ( AVP) was downgraded at UBS to Sell from Neutral. $13 price target. Remain cautious after selloff, UBS said. Boeing ( BA) was upgraded at Argusto to Buy from Hold. $85 price target. Company will benefit from higher commercial flight demand, and airlines are looking to replace aging fleets, Argusto said. Bank of America ( BAC) was downgraded at JMP Securities from Market Perform to Underperform. $5.50 price target. Expect a more strict Volcker rule to be passed, JMP said. Charles River Laboratories International ( CRL) was downgraded to Hold at TheStreet Ratings. Citigroup ( C) was downgraded at JMP Securities to Underperform from Market Perform. Expect a divided Washington to be a headwind for financial stocks, JMP said. $23 price target. First Horizon ( FHN) was upgraded at Guggenheim to Buy. Company can continue to buy back excess capital, Guggenheim said. $10 price target. First Niagara ( FNFG) numbers were cut at Guggenheim. Shares are now seen reaching $9. Estimates were also reduced, given lower yields and high exposure to securities and mortgages, Guggenheim said. Neutral rating. Group 1 Automotive ( GPI) was upgraded at Sterne Agee from Neutral to Buy. Valuation call, based on a $65 price target, Sterne Agee said. Goldman Sachs ( GS) was downgraded at JMP Securities from Outperform to Underperform. $77 price target. See more downside potential for the industry, which is facing multiple headwinds, JMP said. JP Morgan ( JPM) was downgraded at JMP Securities from Market Perform to Underperform. $28 price target. Troubles in Europe will continue to weigh on the industry, JMP Securities said. Manpower Group ( MAN) was downgraded to Hold at TheStreet Ratings. Morgan Stanley ( MS) was downgraded at JMP Securities from Outperform to Underperform. $11 price target. Estimates were also slashed as Greece and other issues should continue to hang over the industry, JMP said. Myriad Genetics ( MYGN) was upgraded at Leerink Swann from Market Perform to Outperform. Reimbursement and IP fears appear overdone, Leerink Swann said.